|
|
| |
|
Product #
|
Description
|
Add to Cart
|
|
SRP3191
|
BLC/BCA-1 (CXCL13) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3019
|
BRAK (CXCL14) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3194
|
CTACK (CCL27) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3195
|
CXCL16 from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3023
|
CXCL16 human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3030
|
ENA-78 (8-78) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP4029
|
Eotaxin from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
|
|
|
|
|
SRP4028
|
Eotaxin human recombinant, expressed in E. coli, ≥97% (SDS-PAGE), ≥97% (HPLC)
|
|
|
|
|
E9152
|
Eotaxin-2 from mouse >95% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder
|
|
|
|
|
E8399
|
Eotaxin-3 human >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
E8403
|
Eotaxin−Biotin from mouse lyophilized powder
|
|
|
|
|
SRP4497
|
Eotaxin-2/CCL24 human recombinant, expressed in E. coli, ≥97% (SDS-PAGE)
|
|
|
|
|
SRP3035
|
Exodus-2 (CCL21) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
G0657
|
GROα human ≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
G7909
|
GROβ human recombinant, expressed in E. coli, cell culture tested
|
|
|
|
|
SRP4107
|
GRO-gamma human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
|
|
|
|
|
SRP4210
|
GRO/KC from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
|
|
|
|
|
SRP3240
|
GRO/KC (CXCL1) from rat recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3053
|
HCC-1 (CCL14) (66 aa) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3054
|
HCC-1 (CCL14) (72 aa) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3098
|
IL-8 (77aa) (CXCL8) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3246
|
IP-10 from rat recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3215
|
JE/MCP-1 (CCL2) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3216
|
KC (CXCL1) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3103
|
LAG-1 (CCL4L1) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3104
|
LD78 beta (CCL3L1) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3105
|
LEC/NCC-4 (CCL16) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3218
|
LIX (70 aa) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3219
|
LIX (CXCL5) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3220
|
Lungkine from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
M6167
|
Macrophage Inflammatory Protein-1α from mouse ≥97% (SDS-PAGE and N-terminal analysis), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
M6292
|
Macrophage Inflammatory Protein-1α human ≥97% (SDS-PAGE and N-terminal analysis), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
M6542
|
Macrophage Inflammatory Protein-1β from mouse recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
|
|
|
|
|
M6417
|
Macrophage Inflammatory Protein-1β human ≥97% (SDS-PAGE and N-terminal analysis), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder, cell culture tested
|
|
|
|
|
SRP3109
|
MCP-1/MCAF human Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3111
|
MDC (67 aa) (CCL22) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3222
|
MDC (CCL22) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3223
|
MEC (CCL28) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3112
|
MEC (CCL28) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
M1439
|
MIG from mouse >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder
|
|
|
|
|
M252
|
MIG human >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
SRP4246
|
MIP-1α from rat recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
|
|
|
|
|
SRP4245
|
MIP-1alpha from mouse recombinant, expressed in E. coli, ≥99% (SDS-PAGE), ≥99% (HPLC)
|
|
|
|
|
SRP4244
|
MIP-1alpha human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
|
|
|
|
|
SRP4248
|
MIP-1beta from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
|
|
|
|
|
SRP4247
|
MIP-1beta human recombinant, expressed in E. coli, ≥99% (SDS-PAGE), ≥99% (HPLC)
|
|
|
|
|
SRP3224
|
MIP-1 alpha (CCL3) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3248
|
MIP-1 alpha (CCL3) from rat recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3249
|
MIP-1 beta from rat recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3115
|
MIP-1 beta (CCL4) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3116
|
MIP-3 (CCL23) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3225
|
MIP-1 gamma (CCL9/10) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
M8543
|
Monocyte Chemotactic Protein-3 human ≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
SRP3121
|
NAP-2 (CXCL7) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3231
|
PF-4 from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3142
|
PF-4 (CXCL4) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
R2274
|
RANTES from mouse >95% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
SRP4323
|
RANTES from rat recombinant, expressed in E. coli, ≥97% (SDS-PAGE), ≥97% (HPLC)
|
|
|
|
|
R6267
|
RANTES human ≥97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
SRP3252
|
SDF-1 alpha from rat recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3253
|
SDF-1 beta from rat recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), cell culture tested
|
|
|
|
|
SRP3214
|
I-TAC (CXCL11) from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3168
|
TECK (CCL25) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
|